Owen J S, McIntyre N
Biochim Biophys Acta. 1978 Jun 16;510(1):168-76. doi: 10.1016/0005-2736(78)90138-4.
In patients with liver disease there are usually increases in erythrocyte cholesterol and phosphatidylcholine concentrations. This increase in membrane lipid changes the shape of the erythrocyte and "spur" or "target" cells may be present. Sodium fluxes were measured in erythrocytes from 17 patients with a variety of liver diseases and from 17 normal subjects and the values related to the lipid content of the membrane. Ouabain-insensitive and ouabain-sensitive effluxes were lower in patients than in normal subjects and the reduction in ouabain-insensitive efflux was more marked. Sodium influx was also significantly lower in erythrocytes from patients than controls. Ouabain-sensitive and ouabain-insensitive effluxes and sodium influx did not correlate with the cholesterol content of erythrocytes from patients. Significant negative correlations were noted between ouabain-insensitive sodium efflux (r=--0.63, P less than 0.01), sodium influx (r=--0.61, P less than 0.01) and intracellular sodium concentration (r=--0.66, P less than 0.01) and the cholesterol : phospholipid molar ratio of the cell but there was no significant correlation between this ratio and the ouabain-sensitive sodium efflux (r=0.41, P less than 0.05). These results support the hypothesis that an altered lipid composition may affect the permeability of the erythrocyte membrane in patients with liver disease.
在肝病患者中,红细胞胆固醇和磷脂酰胆碱浓度通常会升高。膜脂质的这种增加会改变红细胞的形状,可能会出现“棘状”或“靶形”细胞。对17例患有各种肝病的患者和17名正常受试者的红细胞进行钠通量测量,并将测量值与膜的脂质含量相关联。肝病患者中哇巴因不敏感和哇巴因敏感的流出量均低于正常受试者,且哇巴因不敏感流出量的降低更为明显。患者红细胞中的钠流入量也显著低于对照组。患者红细胞中哇巴因敏感和哇巴因不敏感的流出量以及钠流入量与红细胞的胆固醇含量均无相关性。哇巴因不敏感的钠流出量(r = -0.63,P < 0.01)、钠流入量(r = -0.61,P < 0.01)和细胞内钠浓度(r = -0.66,P < 0.01)与细胞的胆固醇:磷脂摩尔比之间存在显著负相关,但该比例与哇巴因敏感的钠流出量之间无显著相关性(r = 0.41,P < 0.05)。这些结果支持了这样一种假说,即脂质组成的改变可能会影响肝病患者红细胞膜的通透性。